| 2024-05-09 |
[Correspondence] People living in prison must be included in country monitoring systems to accurately assess HCV elimination progress |
Lara Tavoschi, Nicola Cocco, Filipa Alves da Costa, Andrey R Lloyd, Stuart A Kinner |
|
| 2024-05-09 |
[Correspondence] Covered versus bare-metal stenting in chronic mesenteric ischaemia – Authors' reply |
Luke G Terlouw, Louisa J D van Dijk, Desirée van Noord, Marco J Bruno |
|
| 2024-05-09 |
[Correspondence] Haematopoietic stem-cell transplantation in Crohn's disease |
Akshita Gupta, Daniela Guisado, Elena Ricart, Jean-Frederic Colombel, Louis Cohen |
|
| 2024-05-09 |
[News] Research in Brief |
Holly Baker |
|
| 2024-05-09 |
[Correspondence] Covered versus bare-metal stenting in chronic mesenteric ischaemia |
Lorenzo Garzelli, Iannis Ben Abdallah, Maxime Ronot |
|
| 2024-05-09 |
[In Focus] Liver transplants: a different kind of theatre |
Peter Ranscombe |
|
| 2024-05-09 |
[In Focus] Our Lives with IBD |
Jennifer Thorley |
|
| 2024-05-09 |
[Correspondence] Equity in clinical trials for hepatitis B |
Tim Mitchell, Jeremy S Nayagam, Mzamo N Mbelle, Kenneth Kabagambe, Kosh Agarwal |
|
| 2024-05-09 |
[Corrections] Correction to Lancet Gastroenterol Hepatol 2024; 9: 507–20 |
|
|
| 2024-05-09 |
[News] Scottish Parliament votes to increase minimum unit price for alcohol |
Udani Samarasekera |
|
| 2024-05-09 |
[Editorial] Urgent action needed to achieve viral hepatitis elimination |
The Lancet Gastroenterology & Hepatology |
|
| 2024-05-09 |
[Articles] A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial |
Sanna Nybacka, Hans Törnblom, Axel Josefsson, Johann P Hreinsson, Lena Böhn, Åsa Frändemark, Cecilia Weznaver, Stine Störsrud, Magnus Simrén |
|
| 2024-05-09 |
[Comment] Managing irritable bowel syndrome: balancing diet and pharmacotherapy |
Uday C Ghoshal, Uzma Mustafa, Mahesh K Goenka |
|
| 2024-05-09 |
[Articles] Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study |
Neil Chanchlani, Simeng Lin, Claire Bewshea, Benjamin Hamilton, Amanda Thomas, Rebecca Smith, Christopher Roberts, Maria Bishara, Rachel Nice, Charlie W Lees, Shaji Sebastian, Peter M Irving, Richard K Russell, Timothy J McDonald, James R Goodhand, Tariq |
|
| 2024-05-09 |
[Comment] PANTS extension study: how best to use anti-TNF drugs in Crohn's disease |
Gareth C Parkes, Charlotte R H Hedin |
|
| 2024-05-09 |
[Comment] WHO 2024 hepatitis B guidelines: an opportunity to transform care |
Philippa J Easterbrook, Niklas Luhmann, Sahar Bajis, Myat Sandi Min, Morkor Newman, Olufunmilayo Lesi, Meg C Doherty |
|
| 2024-05-09 |
[Articles] Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study |
Adrià Ramírez Mena, Mbaye Thiam, Daye Ka, Ibrahima Niang, Judicaël Tine, Louise Fortes, Kiné Ndiaye, Ousseynou Ndiaye, Maguette Fall, Assietou Gaye, Ndeye Fatou Ngom, Fatou Fall, Annalisa Berzigotti, Gregory Dale Kirk, Antoine Jaquet, Moussa Seydi, Gilles |
|
| 2024-05-09 |
[Comment] Liver cancer surveillance in people with hepatitis B in Africa |
Dennis A Ndububa |
|
| 2024-05-09 |
[Review] Ecogastroenterology: cultivating sustainable clinical excellence in an environmentally conscious landscape |
Kassem Sharif, Enrique Rodriguez de Santiago, Paula David, Arnon Afek, Ian M Gralnek, Shomron Ben-Horin, Adi Lahat |
|
| 2024-05-09 |
[Comment] Inconsistencies in the predictive value of PD-L1 in metastatic gastroesophageal cancer |
Raghav Sundar, Elizabeth C Smyth |
|
| 2024-05-09 |
[Viewpoint] Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice |
Paul N Brennan, Oliver D Tavabie, Wenhao Li, Thomas Marjot, Lynsey Corless, Jonathan A Fallowfield, Helen Jarvis, Dina Mansour, Stuart McPherson, William Rosenberg, Karen Rockell, Jeremy Tomlinson, Andrew Yeoman, Emmanuel A Tsochatzis, John F Dillon, Will |
|
| 2024-05-09 |
[Review] Liver transplantation for acute-on-chronic liver failure |
Florent Artru, Francesca Trovato, Maura Morrison, William Bernal, Mark McPhail |
|
| 2024-04-09 |
[Correspondence] Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake |
Yu Wu, Fei Fang |
|
| 2024-04-09 |
[Series] Microbiota therapeutics for inflammatory bowel disease: the way forward |
Lukas Bethlehem, Maria Manuela Estevinho, Ari Grinspan, Fernando Magro, Jeremiah J Faith, Jean-Frederic Colombel |
|
| 2024-04-09 |
[Correspondence] Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake – Authors' reply |
Mads Israelsen, Mary E Rinella, Aleksander Krag |
|
| 2024-04-09 |
[Editorial] Addressing the evolving landscape of global malnutrition |
The Lancet Gastroenterology & Hepatology |
|
| 2024-04-09 |
[Correspondence] NORPACT-1: implications for future trials – Authors' reply |
Knut Jørgen Labori, Svein Olav Bratlie, Svein Dueland, Kristoffer Lassen |
|
| 2024-04-09 |
[News] Research in Brief |
Holly Baker |
|
| 2024-04-09 |
[Comment] Has the time come for a systematic top-down approach in Crohn's disease? |
Mathurin Fumery, Anthony Buisson |
|
| 2024-04-09 |
[Correspondence] NORPACT-1: implications for future trials |
Rebecca A Snyder, Matthew H G Katz |
|
| 2024-04-09 |
[Comment] A women-focused matrix mentorship programme in gastroenterology |
Jalpa Devi, Kathryn Hutchins, Dawn Sears, Anita Afzali, Aline Charabaty |
|
| 2024-04-09 |
[Series] Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics |
Serena Porcari, William Fusco, Igor Spivak, Marcello Fiorani, Antonio Gasbarrini, Eran Elinav, Giovanni Cammarota, Gianluca Ianiro |
|
| 2024-04-09 |
[News] ECCO'24 |
Bethany Gomersall |
|
| 2024-04-09 |
[News] US Government, states reign in insurers' prior authorisation |
Bryant Furlow |
|
| 2024-04-09 |
[Articles] MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial |
Florentine E F Timmer, Bart Geboers, Alette H Ruarus, Laurien G P H Vroomen, Evelien A C Schouten, Susan van der Lei, Danielle J W Vos, Madelon Dijkstra, Hannah H Schulz, Joyce Bakker, Bente A T van den Bemd, Petrousjka M van den Tol, Robbert S Puijk, Bir |
|
| 2024-04-09 |
[Comment] Local ablation in pancreatic cancer: some answers and more questions |
Zachary T Berman, Rebekah R White |
|
| 2024-04-09 |
[Articles] Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial |
Eduard A van Bodegraven, Alberto Balduzzi, Tess M E van Ramshorst, Giuseppe Malleo, Frederique L Vissers, Jony van Hilst, Sebastiaan Festen, Mohammad Abu Hilal, Horacio J Asbun, Nynke Michiels, Bas Groot Koerkamp, Olivier R C Busch, Freek Daams, Misha D P |
|
| 2024-04-09 |
[Comment] Should a no-drain policy after distal pancreatectomy become standard? |
Ulla Klaiber, Oliver Strobel |
|
| 2024-04-09 |
[Articles] Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open-label randomised controlled trial |
Qu Liu, Mengyang Li, Yuanxing Gao, Tao Jiang, Bing Han, Guodong Zhao, Chao Lin, Wan Yee Lau, Zhiming Zhao, Rong Liu |
|
| 2024-04-09 |
[Comment] Robotic pancreatoduodenectomy: preparing for the future |
Elisa Bannone, Giovanni Marchegiani |
|
| 2024-04-09 |
[Comment] Use of immunomodulators in combination with infliximab in Crohn's disease: time for a reappraisal? |
Thomas P Chapman, Tariq Ahmad, Jack Satsangi |
|
| 2024-04-09 |
[Articles] A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial |
Nurulamin M Noor, James C Lee, Simon Bond, Francis Dowling, Biljana Brezina, Kamal V Patel, Tariq Ahmad, Paul J Banim, James W Berrill, Rachel Cooney, Juan De La Revilla Negro, Shanika de Silva, Shahida Din, Dharmaraj Durai, John N Gordon, Peter M Irving, |
|
| 2024-04-09 |
[Comment] Top ten research priorities for alcohol use disorder and alcohol-related liver disease: results of a multistakeholder research priority setting partnership |
Mohsan Subhani, Ashwin Dhanda, Adina Olaru, Louise Dunford, Nahid Ahmad, Andrew Wragg, Kate Frost, Justin Greenwood, Melinda King, Katy A Jones, William Rosenberg, Julia Sinclair, Stefan Rennick-Egglestone, Joanne R Morling, Krishna Patel, Stephen D Ryder |
|
